Richard G Stock

Richard G Stock

UNVERIFIED PROFILE

Are you Richard G Stock?   Register this Author

Register author
Richard G Stock

Richard G Stock

Publications by authors named "Richard G Stock"

Are you Richard G Stock?   Register this Author

100Publications

1197Reads

10Profile Views

Long-term biochemical control and cause-specific survival in men with Gleason grade Group 4 and 5 prostate cancer treated with brachytherapy and external beam irradiation.

Brachytherapy 2020 Mar 23. Epub 2020 Mar 23.

Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.brachy.2020.01.008DOI Listing
March 2020

Prolonged hormonal therapy and external beam radiation independently increase the risk of Persistent Hypogonadism in men treated with prostate brachytherapy.

Brachytherapy 2020 Jan 17. Epub 2020 Jan 17.

Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY; Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.brachy.2019.12.002DOI Listing
January 2020

Permanent prostate brachytherapy is safe in men with severe baseline lower urinary tract symptoms.

Brachytherapy 2019 May - Jun;18(3):332-337. Epub 2019 Mar 16.

Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY; Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.brachy.2019.02.002DOI Listing
December 2019

Long-term oncological and functional outcomes support use of low-dose-rate brachytherapy with or without external beam radiation in young men (≤60 years) with localized prostate cancer.

Brachytherapy 2019 Mar - Apr;18(2):192-197. Epub 2019 Jan 8.

Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY; Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.brachy.2018.12.005DOI Listing
July 2019

Stage T3b prostate cancer diagnosed by seminal vesicle biopsy and treated with neoadjuvant hormone therapy, permanent brachytherapy and external beam radiotherapy.

BJU Int 2019 02 27;123(2):277-283. Epub 2018 Aug 27.

Department of Urology, The Icahn School of Medicine at Mount Sinai, New York, NY, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/bju.14464
Publisher Site
http://dx.doi.org/10.1111/bju.14464DOI Listing
February 2019

Factors influencing long-term urinary symptoms after prostate brachytherapy.

BJU Int 2018 11 31;122(5):831-836. Epub 2018 May 31.

Department of Radiation Oncology, The Icahn School of Medicine at Mount Sinai, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bju.14365DOI Listing
November 2018

Outcomes and toxicities in patients with intermediate-risk prostate cancer treated with brachytherapy alone or brachytherapy and supplemental external beam radiation therapy.

BJU Int 2018 05 16;121(5):774-780. Epub 2018 Feb 16.

Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bju.14128DOI Listing
May 2018

Low-dose-rate brachytherapy for prostate cancer: outcomes at >10 years of follow-up.

BJU Int 2018 05 30;121(5):781-790. Epub 2018 Jan 30.

Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bju.14122DOI Listing
May 2018

Urinary Incontinence Following Prostate Brachytherapy.

Urology 2016 Sep 19;95:151-7. Epub 2016 May 19.

Smith Institute for Urology Northwell Health System, Lake Success, NY. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2016.05.021DOI Listing
September 2016

Diagnosis and management of local recurrence after low-dose-rate brachytherapy.

Brachytherapy 2015 Mar-Apr;14(2):124-30. Epub 2014 Sep 16.

Department of Radiation Oncology, The Icahn School of Medicine at Mount Sinai, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.brachy.2014.08.046DOI Listing
September 2015

15-year cause specific and all-cause survival following brachytherapy for prostate cancer: negative impact of long-term hormonal therapy.

J Urol 2014 Sep 31;192(3):754-9. Epub 2014 Mar 31.

Departments of Urology and Radiation Oncology (RGS), Icahn School of Medicine at Mount Sinai, New York, New York.

View Article

Download full-text PDF

Source
http://www.jurology.com/doi/10.1016/j.juro.2014.03.094
Publisher Site
http://dx.doi.org/10.1016/j.juro.2014.03.094DOI Listing
September 2014

Findings at cystoscopy performed for cause after prostate brachytherapy.

Urology 2014 Jun 3;83(6):1350-5. Epub 2014 Apr 3.

Deane Prostate Health and Research Center, Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY; Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2014.01.031DOI Listing
June 2014

Does dose matter? Editorial comments to Morris et al. Whole prostate D90 and V100: a dose-response analysis of 2000 consecutive (125)I monotherapy cases.

Brachytherapy 2014 Jan-Feb;13(1):42-3. Epub 2013 Dec 15.

Department of Urology, Mount Sinai School of Medicine, New York, NY; Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.brachy.2013.11.009DOI Listing
May 2014

Association of early PSA failure time with increased distant metastasis and decreased survival in prostate brachytherapy patients.

Radiother Oncol 2014 Feb 30;110(2):261-7. Epub 2013 Nov 30.

Department of Radiation Oncology, Mount Sinai Medical Center, New York, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2013.11.003DOI Listing
February 2014

Prostate brachytherapy in men with gland volume of 100cc or greater: Technique, cancer control, and morbidity.

Brachytherapy 2013 May-Jun;12(3):217-21. Epub 2013 Feb 4.

Department of Urology, Mount Sinai School of Medicine, New York, NY10021, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15384721130001
Publisher Site
http://dx.doi.org/10.1016/j.brachy.2012.10.002DOI Listing
November 2013

Risk of urinary incontinence following post-brachytherapy transurethral resection of the prostate and correlation with clinical and treatment parameters.

J Urol 2013 Nov 10;190(5):1805-10. Epub 2013 May 10.

Mount Sinai School of Medicine, New York, New York. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2013.05.010DOI Listing
November 2013

Predictive factors and management of rectal bleeding side effects following prostate cancer brachytherapy.

Int J Radiat Oncol Biol Phys 2013 Aug;86(5):842-7

Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2013.04.033DOI Listing
August 2013

A 2-stage genome-wide association study to identify single nucleotide polymorphisms associated with development of urinary symptoms after radiotherapy for prostate cancer.

J Urol 2013 07 1;190(1):102-8. Epub 2013 Feb 1.

Department of Radiation Oncology, Mount Sinai School of Medicine, New York, New York 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2013.01.096DOI Listing
July 2013

The relative importance of hormonal therapy and biological effective dose in optimizing prostate brachytherapy treatment outcomes.

BJU Int 2013 Jul 14;112(2):E44-50. Epub 2013 Jun 14.

Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bju.12166DOI Listing
July 2013

Haematuria after prostate brachytherapy.

BJU Int 2013 Jun 29;111(8):E319-24. Epub 2013 Jan 29.

Department of Urology, Mount Sinai School of Medicine, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1464-410X.2012.11697.xDOI Listing
June 2013

Temporal patterns of selected late toxicities in patients treated with brachytherapy or brachytherapy plus external beam radiation for prostate adenocarcinoma.

BJU Int 2013 Mar 9;111(3 Pt B):E43-7. Epub 2012 Oct 9.

Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1464-410X.2012.11436.xDOI Listing
March 2013

Biopsy and implantation of the seminal vesicles.

Brachytherapy 2012 Sep-Oct;11(5):334-40. Epub 2012 Feb 2.

Department of Urology, Mount Sinai School of Medicine, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.brachy.2011.12.008DOI Listing
January 2013

Gleason 7 prostate cancer treated with low-dose-rate brachytherapy: lack of impact of primary Gleason pattern on biochemical failure.

BJU Int 2012 Nov 9;110(9):1257-61. Epub 2012 May 9.

Departments of Radiation Oncology Urology, Mount Sinai School of Medicine, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1464-410X.2012.11057.xDOI Listing
November 2012

Long-term potency preservation following brachytherapy for prostate cancer.

BJU Int 2012 Jul 16;110(2):221-5. Epub 2012 Feb 16.

Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1464-410X.2011.10800.xDOI Listing
July 2012

PSA nadir of <0.5 ng/mL following brachytherapy for early-stage prostate adenocarcinoma is associated with freedom from prostate-specific antigen failure.

Int J Radiat Oncol Biol Phys 2012 Jun 8;83(2):600-7. Epub 2011 Oct 8.

Department of Radiation Oncology, Mount Sinai Medical Center, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2011.07.009DOI Listing
June 2012

Intensity-modulated radiotherapy causes fewer side effects than three-dimensional conformal radiotherapy when used in combination with brachytherapy for the treatment of prostate cancer.

Int J Radiat Oncol Biol Phys 2012 Jun 16;83(2):630-5. Epub 2011 Nov 16.

Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03603016110308
Publisher Site
http://dx.doi.org/10.1016/j.ijrobp.2011.06.2013DOI Listing
June 2012

Predictors of metastatic disease after prostate brachytherapy.

Int J Radiat Oncol Biol Phys 2012 Jun 2;83(2):645-52. Epub 2011 Dec 2.

Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2011.07.033DOI Listing
June 2012

Factors influencing urinary symptoms 10 years after permanent prostate seed implantation.

J Urol 2012 Jan 23;187(1):117-23. Epub 2011 Nov 23.

Department of Urology, NNS and Radiation Oncology, Mount Sinai School of Medicine, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2011.09.045DOI Listing
January 2012

Outcomes for patients with extraprostatic prostate cancer treated with trimodality therapy, including brachytherapy, external beam radiotherapy, and hormone therapy.

Brachytherapy 2011 Jul-Aug;10(4):261-8. Epub 2010 Nov 24.

Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.brachy.2010.10.002DOI Listing
December 2011

Update on prostate brachytherapy: long-term outcomes and treatment-related morbidity.

Curr Urol Rep 2011 Jun;12(3):237-42

Florida Cancer Physicians Network, Florida Radiation Oncology Group, 717 West Robertson Street, Brandon, FL 33511, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11934-011-0183-3DOI Listing
June 2011

Association between number of cell phone contracts and brain tumor incidence in nineteen U.S. States.

J Neurooncol 2011 Feb 30;101(3):505-7. Epub 2010 Jun 30.

Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-010-0280-zDOI Listing
February 2011

Counterpoint: there is a dose-response relationship in the low-dose rate brachytherapy management of prostate cancer.

Authors:
Richard G Stock

Brachytherapy 2010 Oct-Dec;9(4):293-6; discussion 299. Epub 2010 Sep 15.

Department of Radiation Oncology, Mount Sinai School of Medicine, 1184 5th Ave, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.brachy.2010.08.001DOI Listing
February 2011

Influence of pretreatment and treatment factors on intermediate to long-term outcome after prostate brachytherapy.

J Urol 2011 Feb 17;185(2):495-500. Epub 2010 Dec 17.

Department of Urology, Mount Sinai School of Medicine, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2010.09.099DOI Listing
February 2011

Young men have equivalent biochemical outcomes compared with older men after treatment with brachytherapy for prostate cancer.

Int J Radiat Oncol Biol Phys 2010 Aug 13;77(5):1315-21. Epub 2010 Jan 13.

Department of Radiation Oncology, Mount Sinai School of Medicine, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2009.06.052DOI Listing
August 2010

Long-term outcome and toxicity of salvage brachytherapy for local failure after initial radiotherapy for prostate cancer.

Int J Radiat Oncol Biol Phys 2010 Aug;77(5):1338-44

Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2009.06.061DOI Listing
August 2010

Do high radiation doses in locally advanced prostate cancer patients treated with 103Pd implant plus external beam irradiation cause increased urinary, rectal, and sexual morbidity?

Brachytherapy 2010 Apr-Jun;9(2):114-8. Epub 2009 Oct 30.

Department of Urology, Mount Sinai School of Medicine, New York, NY 10075, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.brachy.2009.08.002DOI Listing
June 2010

Local control following permanent prostate brachytherapy: effect of high biologically effective dose on biopsy results and oncologic outcomes.

Int J Radiat Oncol Biol Phys 2010 Feb 23;76(2):355-60. Epub 2009 Jul 23.

Department of Urology, Mount Sinai School of Medicine, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2009.01.078DOI Listing
February 2010

Impact of hormonal therapy on intermediate risk prostate cancer treated with combination brachytherapy and external beam irradiation.

J Urol 2010 Feb 14;183(2):546-50. Epub 2009 Dec 14.

Department of Radiation Oncology and Urology, Mount Sinai School of Medicine, New York, New York 10025, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2009.10.006DOI Listing
February 2010

Does neoadjuvant hormonal therapy improve urinary function when given to men with large prostates undergoing prostate brachytherapy?

J Urol 2010 Feb 16;183(2):634-9. Epub 2009 Dec 16.

Departments of Urology, Mount Sinai School of Medicine, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2009.09.084DOI Listing
February 2010

Current topics in the treatment of prostate cancer with low-dose-rate brachytherapy.

Urol Clin North Am 2010 Feb;37(1):83-96, Table of Contents

Department of Radiation Oncology, Mount Sinai School of Medicine, Mount Sinai Hospital, 1184 5th Avenue, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ucl.2009.11.013DOI Listing
February 2010

Outcomes for patients with high-grade prostate cancer treated with a combination of brachytherapy, external beam radiotherapy and hormonal therapy.

BJU Int 2009 Dec 2;104(11):1631-6. Epub 2009 Jun 2.

Departments of Radiation Oncology and Urology, Mount Sinai School of Medicine, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1464-410X.2009.08661.xDOI Listing
December 2009

Radiation dose predicts for biochemical control in intermediate-risk prostate cancer patients treated with low-dose-rate brachytherapy.

Int J Radiat Oncol Biol Phys 2009 Sep 14;75(1):16-22. Epub 2009 Mar 14.

Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2008.10.071DOI Listing
September 2009

Prognostic significance of 5-year PSA value for predicting prostate cancer recurrence after brachytherapy alone and combined with hormonal therapy and/or external beam radiotherapy.

Int J Radiat Oncol Biol Phys 2009 Jul 10;74(3):753-8. Epub 2008 Dec 10.

Department of Radiation Oncology, Mount Sinai Hospital, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2008.08.049DOI Listing
July 2009

There is no correlation between erectile dysfunction and dose to penile bulb and neurovascular bundles following real-time low-dose-rate prostate brachytherapy.

Int J Radiat Oncol Biol Phys 2009 Apr 14;73(5):1468-74. Epub 2008 Oct 14.

Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY 10029-6574, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2008.06.1946DOI Listing
April 2009

Effect of family history on outcomes in patients treated with definitive brachytherapy for clinically localized prostate cancer.

Int J Radiat Oncol Biol Phys 2009 Jan 7;73(1):24-9. Epub 2008 Aug 7.

Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2008.04.031DOI Listing
January 2009

Counterpoint: High-risk prostate cancer: the case for combination brachytherapy and external beam irradiation.

Authors:
Richard G Stock

Brachytherapy 2008 Oct-Dec;7(4):280-2; discussion 283

Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY 10025, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.brachy.2008.08.005DOI Listing
January 2009

Bisphosphonate-induced osteonecrosis of the jaws, bone markers, and a hypothesized candidate gene.

J Oral Maxillofac Surg 2009 Jan;67(1):159-61

Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.joms.2008.09.015DOI Listing
January 2009

Distant and local recurrence in patients with biochemical failure after prostate brachytherapy.

Brachytherapy 2008 Jul-Sep;7(3):217-22

Department of Radiation Oncology, Mount Sinai School of Medicine, 1184 5th Avenue, New York, NY 10025, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.brachy.2008.04.002DOI Listing
November 2008

Normal serum bone markers in bisphosphonate-induced osteonecrosis of the jaws.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008 Sep 13;106(3):389-91. Epub 2008 Jun 13.

Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.tripleo.2008.01.033DOI Listing
September 2008

TGFB1 single nucleotide polymorphisms are associated with adverse quality of life in prostate cancer patients treated with radiotherapy.

Int J Radiat Oncol Biol Phys 2008 Mar 8;70(3):752-9. Epub 2007 Aug 8.

Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2007.05.023DOI Listing
March 2008

Brachytherapy for the treatment of prostate cancer.

Cancer J 2007 Sep-Oct;13(5):302-12

Department of Radiation Oncology, The Mount Sinai School of Medicine, James J. Peters VA Hospital, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PPO.0b013e318156dcbeDOI Listing
January 2008

(125)I monotherapy using D90 implant doses of 180 Gy or greater.

Int J Radiat Oncol Biol Phys 2008 Jan 5;70(1):96-101. Epub 2007 Nov 5.

Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2007.06.067DOI Listing
January 2008

Possession of ATM sequence variants as predictor for late normal tissue responses in breast cancer patients treated with radiotherapy.

Int J Radiat Oncol Biol Phys 2007 Nov 22;69(3):677-84. Epub 2007 May 22.

Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2007.04.012DOI Listing
November 2007

A genetically determined dose-volume histogram predicts for rectal bleeding among patients treated with prostate brachytherapy.

Int J Radiat Oncol Biol Phys 2007 Aug 9;68(5):1410-6. Epub 2007 May 9.

Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2007.02.052DOI Listing
August 2007

Effect of low dose-rate prostate brachytherapy on the sexual health of men with optimal sexual function before treatment: analysis at > or = 7 years of follow-up.

BJU Int 2007 Aug;100(2):362-7

Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1464-410X.2007.07016.xDOI Listing
August 2007

Assessment of postbrachytherapy sexual function: a comparison of the IIEF-5 and the MSEFS.

Brachytherapy 2007 Jan-Mar;6(1):26-33

Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.brachy.2006.11.003DOI Listing
May 2007

Patterns of local failure following prostate brachytherapy.

J Urol 2007 May;177(5):1759-63; duscussion 1763-4

Department of Urology, Mount Sinai School of Medicine, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2007.01.069DOI Listing
May 2007

The effect of brachytherapy, external beam irradiation and hormonal therapy on prostate volume.

J Urol 2007 Mar;177(3):925-8

Department of Urology, Mount Sinai School of Medicine, New York, New York, USA.

View Article

Download full-text PDF

Source
http://www.jurology.com/doi/10.1016/j.juro.2006.10.018
Publisher Site
http://dx.doi.org/10.1016/j.juro.2006.10.018DOI Listing
March 2007

Long-term urinary, sexual, and rectal morbidity in patients treated with iodine-125 prostate brachytherapy followed up for a minimum of 5 years.

Urology 2007 Feb;69(2):338-42

Department of Urology, Mount Sinai School of Medicine, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2006.10.001DOI Listing
February 2007

Low-dose rate prostate brachytherapy is well tolerated in patients with a history of inflammatory bowel disease.

Int J Radiat Oncol Biol Phys 2006 Oct 2;66(2):424-9. Epub 2006 Aug 2.

Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2006.05.027DOI Listing
October 2006

Changing the patterns of failure for high-risk prostate cancer patients by optimizing local control.

Int J Radiat Oncol Biol Phys 2006 Oct;66(2):389-94

Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2006.05.072DOI Listing
October 2006

High-dose-rate versus low-dose-rate monotherapy in the treatment of localized prostate cancer: The case for low-dose-rate monotherapy.

Authors:
Richard G Stock

Brachytherapy 2006 Jan-Mar;5(1):5-6; discussion 8

Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.brachy.2006.01.003DOI Listing
May 2006

Disease-specific survival following the brachytherapy management of prostate cancer.

Int J Radiat Oncol Biol Phys 2006 Mar 23;64(3):810-6. Epub 2005 Nov 23.

Department of Radiation Oncology, Mount Sinai Hospital, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2005.09.005DOI Listing
March 2006

ATM sequence variants and risk of radiation-induced subcutaneous fibrosis after postmastectomy radiotherapy.

Int J Radiat Oncol Biol Phys 2006 Mar 9;64(3):776-83. Epub 2005 Dec 9.

Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2005.09.014DOI Listing
March 2006

Critical organ dosimetry in permanent seed prostate brachytherapy: defining the organs at risk.

Brachytherapy 2005 ;4(3):186-94

Department of Radiation Oncology, Princess Margaret Hospital, Toronto, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.brachy.2005.01.002DOI Listing
February 2006

Biologically effective dose values for prostate brachytherapy: effects on PSA failure and posttreatment biopsy results.

Int J Radiat Oncol Biol Phys 2006 Feb 19;64(2):527-33. Epub 2005 Oct 19.

Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2005.07.981DOI Listing
February 2006

Serum thyroid-stimulating hormone is elevated in men with Gleason 8 prostate cancer.

BJU Int 2005 Aug;96(3):328-9

Department of Radiation Oncology, Mount Sinai Medical Center, Bronx, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1464-410X.2005.05625.xDOI Listing
August 2005

Reduction of pulmonary migration of permanent interstitial sources in patients undergoing prostate brachytherapy.

Urology 2005 Jul;66(1):119-23

Department of Urology, Mount Sinai School of Medicine, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2005.01.047DOI Listing
July 2005

C-reactive protein is significantly associated with prostate-specific antigen and metastatic disease in prostate cancer.

BJU Int 2005 May;95(7):961-2

Department of Radiation Oncology, Mount Sinai Medical Center, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1464-410X.2005.05447.xDOI Listing
May 2005

Intermediate term biochemical-free progression and local control following 125iodine brachytherapy for prostate cancer.

J Urol 2005 Mar;173(3):803-7

Department of Urology, Mount Sinai School of Medicine, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.ju.0000152558.63996.29DOI Listing
March 2005

Prostate cancer in a large prostate is associated with a decreased prostate specific antigen failure rate after brachytherapy.

J Urol 2005 Jan;173(1):79-81

Department of Radiation Oncology and Urology, Mount Sinai Medical Center, 1 Gustave L. Levy Place, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.ju.0000145827.20277.e9DOI Listing
January 2005

Does prior transurethral resection of prostate compromise brachytherapy quality: a dosimetric analysis.

Int J Radiat Oncol Biol Phys 2004 Oct;60(2):648-53

Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2004.05.070DOI Listing
October 2004

Combined modality treatment in the management of high-risk prostate cancer.

Int J Radiat Oncol Biol Phys 2004 Aug;59(5):1352-9

Department of Radiation Oncology, Mount Sinai School of Medicine, Box 1236, 1184 5th Avenue, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2004.01.023DOI Listing
August 2004

What is the optimal dose for 125I prostate implants? A dose-response analysis of biochemical control, posttreatment prostate biopsies, and long-term urinary symptoms.

Brachytherapy 2002 ;1(2):83-9

Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s1538-4721(02)00017-xDOI Listing
June 2004

Prostate gland motion and deformation caused by needle placement during brachytherapy.

Brachytherapy 2002 ;1(3):154-60

Department of Urology, Mount Sinai School of Medicine, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s1538-4721(02)00058-2DOI Listing
May 2004

The role of hormonal therapy in prostate brachytherapy. Point.

Authors:
Richard G Stock

Brachytherapy 2003 ;2(1):1-2

Department of Radiation Oncology, Mount Sinai Medical Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1538-4721(03)00011-4DOI Listing
April 2004

Prospective assessment of patient-reported long-term urinary morbidity and associated quality of life changes after 125I prostate brachytherapy.

Brachytherapy 2003 ;2(1):32-9

Department of Urology, Mount Sinai School of Medicine, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1538-4721(03)00012-6DOI Listing
April 2004

Influence of prostate volume on dosimetry results in real-time 125I seed implantation.

Int J Radiat Oncol Biol Phys 2004 Jan;58(1):292-9

Department of Radiation Oncology, Boulder Community Hospital, Boulder, CO, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0360-3016(03)00783-1DOI Listing
January 2004

Biochemical outcomes after prostate brachytherapy with 5-year minimal follow-up: importance of patient selection and implant quality.

Int J Radiat Oncol Biol Phys 2003 Nov;57(3):645-53

Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0360-3016(03)00627-8DOI Listing
November 2003